Public Employees Retirement Association of Colorado’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Hold
13,746
﹤0.01% 1333
2026
Q1
$321K Hold
13,746
﹤0.01% 1207
2025
Q4
$289K Hold
13,746
﹤0.01% 1278
2025
Q3
$211K Hold
13,746
﹤0.01% 1443
2025
Q2
$129K Hold
13,746
﹤0.01% 1609
2025
Q1
$169K Hold
13,746
﹤0.01% 1509
2024
Q4
$182K Hold
13,746
﹤0.01% 1551
2024
Q3
$265K Hold
13,746
﹤0.01% 1374
2024
Q2
$282K Sell
13,746
-2,478
-15% -$51.9K ﹤0.01% 1286
2024
Q1
$386K Sell
16,224
-5,687
-26% -$127K ﹤0.01% 1132
2023
Q4
$473K Sell
21,911
-2,834
-11% -$43.6K ﹤0.01% 1034
2023
Q3
$359K Sell
24,745
-4,681
-16% -$88.5K ﹤0.01% 1164
2023
Q2
$616K Buy
+29,426
New +$613K ﹤0.01% 915

Other funds holding SNDX

Public Employees Retirement Association of Colorado's SNDX Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 13,746 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Public Employees Retirement Association of Colorado first reported a position in SNDX in Q2 2023 and has held it in 13 quarters since. The position peaked at $616K in Q2 2023. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Public Employees Retirement Association of Colorado held 13,746 shares of Syndax Pharmaceuticals worth $300K as of Q2 2026.
  • Public Employees Retirement Association of Colorado left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #1333 holding.
  • Public Employees Retirement Association of Colorado first reported a position in Syndax Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Public Employees Retirement Association of Colorado's Syndax Pharmaceuticals position peaked at $616K in Q2 2023.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.